{"id":"https://openalex.org/W2742058366","doi":"https://doi.org/10.1158/1538-7445.am2017-5067","title":"Abstract 5067: BET protein proteolysis targeting chimera (BETP-PROTACs) exert more potent activity than BETP bromodomain inhibitor (BETi) against post-myeloproliferative neoplasm (MPN) secondary (s) AML cells","display_name":"Abstract 5067: BET protein proteolysis targeting chimera (BETP-PROTACs) exert more potent activity than BETP bromodomain inhibitor (BETi) against post-myeloproliferative neoplasm (MPN) secondary (s) AML cells","publication_year":2017,"publication_date":"2017-07-01","ids":{"openalex":"https://openalex.org/W2742058366","doi":"https://doi.org/10.1158/1538-7445.am2017-5067","mag":"2742058366"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2017-5067","doi":"https://doi.org/10.1158/1538-7445.am2017-5067","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2017-5067","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5000534025","display_name":"Dyana T. Saenz","orcid":"https://orcid.org/0000-0001-5935-977X","observed_orcids":["https://orcid.org/0000-0001-5935-977X"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dyana T. Saenz","raw_affiliation_strings":["1MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067678169","display_name":"Warren C. Fiskus","orcid":"https://orcid.org/0000-0002-7343-6214","observed_orcids":["https://orcid.org/0000-0002-7343-6214"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Warren C. Fiskus","raw_affiliation_strings":["1MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038644541","display_name":"Kanak Raina","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210142342","display_name":"Arvinas (United States)","ror":"https://ror.org/045jkfr03","country_code":"US","type":"company","lineage":["https://openalex.org/I4210142342"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kanak Raina","raw_affiliation_strings":["2Arvinas, LLC, New Haven, CT;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Arvinas, LLC, New Haven, CT;","institution_ids":["https://openalex.org/I4210142342"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008109253","display_name":"Taghi Manshouri","orcid":"https://orcid.org/0000-0003-1192-1465","observed_orcids":["https://orcid.org/0000-0003-1192-1465"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Taghi Manshouri","raw_affiliation_strings":["1MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109504130","display_name":"Kevin G. Coleman","orcid":"https://orcid.org/0009-0009-6445-2931","observed_orcids":["https://orcid.org/0009-0009-6445-2931"]},"institutions":[{"id":"https://openalex.org/I4210142342","display_name":"Arvinas (United States)","ror":"https://ror.org/045jkfr03","country_code":"US","type":"company","lineage":["https://openalex.org/I4210142342"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kevin G. Coleman","raw_affiliation_strings":["2Arvinas, LLC, New Haven, CT;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Arvinas, LLC, New Haven, CT;","institution_ids":["https://openalex.org/I4210142342"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021167157","display_name":"Yimin Qian","orcid":"https://orcid.org/0000-0003-2377-7931","observed_orcids":["https://orcid.org/0000-0003-2377-7931"]},"institutions":[{"id":"https://openalex.org/I4210142342","display_name":"Arvinas (United States)","ror":"https://ror.org/045jkfr03","country_code":"US","type":"company","lineage":["https://openalex.org/I4210142342"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yimin Qian","raw_affiliation_strings":["2Arvinas, LLC, New Haven, CT;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Arvinas, LLC, New Haven, CT;","institution_ids":["https://openalex.org/I4210142342"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007702221","display_name":"Andrew P. A. Crew","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210142342","display_name":"Arvinas (United States)","ror":"https://ror.org/045jkfr03","country_code":"US","type":"company","lineage":["https://openalex.org/I4210142342"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrew P. Crew","raw_affiliation_strings":["2Arvinas, LLC, New Haven, CT;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Arvinas, LLC, New Haven, CT;","institution_ids":["https://openalex.org/I4210142342"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103090937","display_name":"Angela Shen","orcid":"https://orcid.org/0000-0002-1131-1280","observed_orcids":["https://orcid.org/0000-0002-1131-1280"]},"institutions":[{"id":"https://openalex.org/I4210142342","display_name":"Arvinas (United States)","ror":"https://ror.org/045jkfr03","country_code":"US","type":"company","lineage":["https://openalex.org/I4210142342"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Angela Shen","raw_affiliation_strings":["2Arvinas, LLC, New Haven, CT;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Arvinas, LLC, New Haven, CT;","institution_ids":["https://openalex.org/I4210142342"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013802454","display_name":"Christopher Peter Mill","orcid":"https://orcid.org/0000-0003-0957-6009","observed_orcids":["https://orcid.org/0000-0003-0957-6009"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christopher P. Mill","raw_affiliation_strings":["1MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056040915","display_name":"Baohua Sun","orcid":"https://orcid.org/0000-0003-0393-8099","observed_orcids":["https://orcid.org/0000-0003-0393-8099"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Baohua Sun","raw_affiliation_strings":["1MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101660496","display_name":"Mi-Sun Kim","orcid":"https://orcid.org/0000-0003-3771-6101","observed_orcids":["https://orcid.org/0000-0003-3771-6101"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Misun Kim","raw_affiliation_strings":["1MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026519458","display_name":"Agnieszka J. Nowak","orcid":"https://orcid.org/0000-0002-1947-9299","observed_orcids":["https://orcid.org/0000-0002-1947-9299"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Agnieszka J. Nowak","raw_affiliation_strings":["1MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085521139","display_name":"Sr\u0111an Verstov\u0161ek","orcid":"https://orcid.org/0000-0002-6912-8569","observed_orcids":["https://orcid.org/0000-0002-6912-8569"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Srdan Verstovsek","raw_affiliation_strings":["1MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016866989","display_name":"Craig M. Crews","orcid":"https://orcid.org/0000-0002-8456-2005","observed_orcids":["https://orcid.org/0000-0002-8456-2005"]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Craig M. Crews","raw_affiliation_strings":["3Yale University, New Haven, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Yale University, New Haven, CT","institution_ids":["https://openalex.org/I32971472"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5079069209","display_name":"Kapil N. Bhalla","orcid":"https://orcid.org/0000-0001-5209-5126","observed_orcids":["https://orcid.org/0000-0001-5209-5126"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kapil N. Bhalla","raw_affiliation_strings":["1MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"77","issue":"13_Supplement","first_page":"5067","last_page":"5067"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11628","display_name":"Myeloproliferative Neoplasms: Diagnosis and Treatment","score":0.002300000051036477,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/protacs","display_name":"PROTACs","score":0.8629999756813049},{"id":"https://openalex.org/keywords/bet-inhibitors","display_name":"BET inhibitors","score":0.8270000219345093},{"id":"https://openalex.org/keywords/myelofibrosis","display_name":"myelofibrosis","score":0.7279999852180481},{"id":"https://openalex.org/keywords/brd4-degradation","display_name":"BRD4 degradation","score":0.8370000123977661},{"id":"https://openalex.org/keywords/arv-825","display_name":"ARV-825","score":0.8740000128746033},{"id":"https://openalex.org/keywords/c-myc","display_name":"c-Myc","score":0.6320000290870667},{"id":"https://openalex.org/keywords/jak2-v617f-mutation","display_name":"JAK2 V617F mutation","score":0.8259999752044678},{"id":"https://openalex.org/keywords/tp53-mutation","display_name":"TP53 mutation","score":0.7570000290870667},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.7250000238418579},{"id":"https://openalex.org/keywords/jak1-2-inhibition","display_name":"JAK1/2 inhibition","score":0.4909999966621399},{"id":"https://openalex.org/keywords/ruxolitinib-resistance","display_name":"ruxolitinib resistance","score":0.8240000009536743},{"id":"https://openalex.org/keywords/drug-repurposing","display_name":"drug repurposing","score":0.3869999945163727}],"concepts":[{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5930876135826111},{"id":"https://openalex.org/C109159458","wikidata":"https://www.wikidata.org/wiki/Q919283","display_name":"Haematopoiesis","level":3,"score":0.5624562501907349},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.48212242126464844},{"id":"https://openalex.org/C28328180","wikidata":"https://www.wikidata.org/wiki/Q48196","display_name":"Stem cell","level":2,"score":0.4668481945991516},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4564637243747711},{"id":"https://openalex.org/C10205521","wikidata":"https://www.wikidata.org/wiki/Q4035578","display_name":"CD34","level":3,"score":0.4321361780166626},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.3774895668029785},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.30911803245544434},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.1644642949104309}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2017-5067","doi":"https://doi.org/10.1158/1538-7445.am2017-5067","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2017-5067","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2589196241","https://openalex.org/W2752438494","https://openalex.org/W2525068643","https://openalex.org/W2523137892","https://openalex.org/W2500133046","https://openalex.org/W2563465351","https://openalex.org/W4240622604","https://openalex.org/W2979424271","https://openalex.org/W7108449130","https://openalex.org/W3155335715"],"abstract_inverted_index":{"Abstract":[0],"In":[1,144],"BCR-ABL1-negative":[2],"myeloproliferative":[3],"neoplasms":[4],"with":[5,56,123,249,310,315,332,355,362,369,388],"myelofibrosis":[6],"(MPN-MF)":[7],"transformation":[8],"to":[9,15,126,247,308,353],"AML":[10,478],"(sAML)":[11],"occurs":[12],"in":[13,34,47,117,159,178,214,295,367,374,397],"up":[14,222],"20%":[16],"of":[17,37,67,98,111,129,138,181,205,208,226,255,269,383,400,483],"patients.":[18],"Ruxolitinib":[19],"(R)":[20],"is":[21,32],"a":[22],"type":[23],"I,":[24],"ATP-competitive,":[25],"JAK1":[26],"&":[27],"2":[28],"inhibitor":[29,336,470],"(JAKi),":[30],"which":[31,133],"effective":[33],"the":[35,44,95,109,118,127,160,176,192,206,215,266,296,323,373,380,384,401,415,484],"therapy":[36],"MPN-MF":[38],"but":[39],"does":[40],"not":[41,412],"significantly":[42,172,371],"impact":[43],"clinical":[45],"outcome":[46],"post-MPN":[48,406],"sAML.":[49,407],"We":[50],"have":[51],"previously":[52],"reported":[53],"that":[54,73,280],"treatment":[55,93,122,219,248,309,354,359,361],"BETi,":[57,232,250],"e.g.":[58,80,131],"JQ1":[59],"or":[60,276,338,366],"OTX015":[61,284],"inhibits":[62],"growth":[63],"and":[64,77,82,104,115,141,151,162,183,202,223,228,237,263,271,289,305,317,325,334,347,378],"induces":[65],"apoptosis":[66,180],"cultured":[68,161,182,324],"sAML":[69,90,119,165,185,216,298,328,349,376],"cells,":[70],"including":[71,210],"those":[72],"express":[74],"JAK2":[75],"V617F":[76],"mutant":[78],"TP53,":[79],"HEL92.1.7":[81,390],"SET2,":[83],"as":[84,86,233],"well":[85],"patient-derived":[87],"(PD)":[88],"CD34+":[89,164,193,297,327],"cells.":[91,120,166,197,217,329,350,391],"BETi":[92,124,177],"attenuated":[94],"protein":[96,229,240,267,458],"expressions":[97,230],"c-MYC,":[99,139,256],"p-STAT5,":[100,258],"Bcl-xL,":[101,264],"CDK4/6,":[102],"PIM1":[103,262],"IL-7R,":[105],"while":[106,190,291],"concomitantly":[107],"inducing":[108,179,292],"levels":[110,207,268,294],"HEXIM1,":[112],"p21,":[113],"NOXA":[114],"BIM":[116],"However,":[121],"leads":[125],"accumulation":[128],"BETP,":[130],"BRD4,":[132,287],"may":[134],"reduce":[135],"BETi-mediated":[136],"repression":[137],"NF\u03baB":[140],"BETP-regulated":[142],"oncoproteins.":[143],"contrast,":[145],"BETP-PROTACs":[146,170,199],"(proteolysis":[147],"targeting":[148,460],"chimera)":[149],"ARV-825":[150],"ARV-771":[152,364],"(Arvinas":[153],"Inc.)":[154],"degrade":[155],"BETPs":[156],"(including":[157],"BRD4)":[158],"PD":[163,184,326],"At":[167],"equimolar":[168],"concentrations,":[169],"were":[171,273],"more":[173,221,282,464],"potent":[174,465],"than":[175,231,283,467],"cells":[186,300,479],"(p":[187],"<":[188],"0.05),":[189],"sparing":[191],"normal":[194],"hematopoietic":[195],"progenitor":[196],"Notably,":[198],"caused":[200,220,252],"efficient":[201],"prolonged":[203],"depletion":[204,254],"BETPs,":[209],"BRD4":[211],"(>":[212],"90%)":[213],"BETP-PROTAC":[218,251,316,333,363],"down":[224],"regulation":[225],"mRNA":[227],"determined":[234],"by":[235],"RNA-Seq":[236],"reversed":[238],"phase":[239],"array":[241],"(RPPA)":[242],"analyses,":[243],"respectively.":[244],"As":[245,351],"compared":[246,352],"greater":[253],"JAK2,":[257],"STAT5,":[259],"p-STAT3,":[260],"STAT3,":[261],"whereas":[265],"p21":[270,293],"p27":[272],"upregulated.":[274],"CyTOF":[275],"mass-cytometry":[277],"also":[278],"showed":[279],"BETP-PROTAC,":[281],"treatment,":[285],"reduced":[286,372],"c-MYC":[288],"p-Rb,":[290],"stem/progenitor":[299],"expressing":[301],"CD90,":[302],"CD244,":[303],"CD123":[304],"TIM3-Fc.":[306],"Compared":[307],"each":[311],"agent":[312],"alone,":[313,360],"co-treatment":[314,331],"R":[318,358,370],"was":[319,342,411],"synergistically":[320,343],"lethal":[321,344],"against":[322,345,405,472],"Additionally,":[330],"HSP90":[335],"AUY922":[337],"BCL2/BcL-xL":[339],"antagonist":[340],"ABT263":[341],"R-sensitive":[346],"R-resistant":[348],"vehicle":[356],"control,":[357],"alone":[365],"combination":[368],"vivo":[375,398],"burden":[377],"improved":[379],"median":[381],"survival":[382],"immune-depleted":[385],"mice":[386],"engrafted":[387],"luciferase-transduced":[389],"These":[392],"findings":[393],"strongly":[394],"support":[395],"further":[396],"development":[399],"novel":[402],"BETP-PROTACs-based":[403],"combinations":[404],"Note:":[408],"This":[409],"abstract":[410],"presented":[413],"at":[414],"meeting.":[416],"Citation":[417],"Format:":[418],"Dyana":[419],"T.":[420],"Saenz,":[421],"Warren":[422],"C.":[423],"Fiskus,":[424],"Kanak":[425],"Raina,":[426],"Taghi":[427],"Manshouri,":[428],"Kevin":[429],"G.":[430],"Coleman,":[431],"Yimin":[432],"Qian,":[433],"Andrew":[434],"P.":[435,440],"Crew,":[436],"Angela":[437],"Shen,":[438],"Christopher":[439],"Mill,":[441],"Baohua":[442],"Sun,":[443],"Misun":[444],"Kim,":[445],"Agnieszka":[446],"J.":[447],"Nowak,":[448],"Srdan":[449],"Verstovsek,":[450],"Craig":[451],"M.":[452],"Crews,":[453],"Kapil":[454],"N.":[455],"Bhalla.":[456],"BET":[457],"proteolysis":[459],"chimera":[461],"(BETP-PROTACs)":[462],"exert":[463],"activity":[466],"BETP":[468],"bromodomain":[469],"(BETi)":[471],"post-myeloproliferative":[473],"neoplasm":[474],"(MPN)":[475],"secondary":[476],"(s)":[477],"[abstract].":[480],"In:":[481],"Proceedings":[482],"American":[485],"Association":[486],"for":[487],"Cancer":[488,501],"Research":[489],"Annual":[490],"Meeting":[491],"2017;":[492],"2017":[493],"Apr":[494],"1-5;":[495],"Washington,":[496],"DC.":[497],"Philadelphia":[498],"(PA):":[499],"AACR;":[500],"Res":[502],"2017;77(13":[503],"Suppl):Abstract":[504],"nr":[505],"5067.":[506],"doi:10.1158/1538-7445.AM2017-5067":[507]},"counts_by_year":[{"year":2026,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2017-08-08T00:00:00"}